Abstract:Background Defects in the alpha-synuclein, leucine-rich repeat kinase 2, or glucocerebrosidase genes have been regarded as essential contributors to PD. However, genetic variability of these genes with respect to early-onset PD remains poorly defined for the Chinese demographic. Objectives We aim to systematically characterize the clinical and genetic architecture of alpha-synuclein, leucine-rich repeat kinase 2, and glucocerebrosidase in Chinese early-onset PD patients. Methods Whole-exome sequencing and Sanger sequencing were used to identify variants of alpha-synuclein, leucine-rich repeat kinase 2, and glucocerebrosidase in 662 Chinese early-onset PD patients. Haplotype and burden analyses were conducted to investigate the role of rare variants of these three genes in early-onset PD. Results Sixty rare variants, including 23 novel variants, were identified in 73 patients (11.0%). Frequencies of patients with rare pathogenic/likely pathogenic variants of alpha-synuclein, leucine-rich repeat kinase 2, and glucocerebrosidase were 0.6%, 3.0%, and 5.4%, respectively. Evidences of two founder events exclusive to Asians were identified in 2 patients with leucine-rich repeat kinase 2 p.R1441C and 3 patients with alpha-synuclein p.A53V. Gene-based burden analysis supported glucocerebrosidase as a strong risk factor for early-onset PD, but argued against over-representation of rare variants in alpha-synuclein or leucine-rich repeat kinase 2 in early-onset PD. Clinically, no differences in motor or nonmotor symptoms were found between glucocerebrosidase variants carriers, and noncarriers or between leucine-rich repeat kinase 2 carriers and noncarriers. Patients with alpha-synuclein variants showed both rapid progression and worse cognitive impairment. Conclusion Our study provides a better understanding of the clinical and genetic correlations of alpha-synuclein, leucine-rich repeat kinase 2, and glucocerebrosidase in early-onset PD, which may be beneficial for drafting genetic scanning strategies and evaluating disease progression. (c) 2020 International Parkinson and Movement Disorder Society

Clinical profiles of Parkinson's disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals

Clinical and Functional Evidence for the Pathogenicity of the LRRK2 P.arg1067gln Variant

Evaluating the Role of SNCA, LRRK2, and GBA in Chinese Patients with Early‐Onset Parkinson's Disease

Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.

Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson's Disease Patients.

The association between clinical phenotype of Parkinson’s disease and LRRK2 variants in China

Analysis of Rare Variants of Autosomal‐dominant Genes in a Chinese Population with Sporadic Parkinson’s Disease

Genetic Analysis of LRRK2 in Parkinson's Disease in Han Chinese Population.

Genetic Analysis of ATP13A2, PLA2G6 and FBXO7 in a Cohort of Chinese Patients with Early-Onset Parkinson's Disease.

Prevalence of Pre-Diagnostic Symptoms Did Not Differ Between LRRK2-related, GBA-related and Idiopathic Patients with Parkinson's Disease.

Correlation between LRRK2 gene polymorphism sites S1647T and R1398H and Parkinson's disease in a Chinese Han population

Clinical features and progression of Parkinson's disease with LRRK2 variants: A prospective study

Rare Variants Analysis of Lysosomal Related Genes in Early-Onset and Familial Parkinson's Disease in a Chinese Cohort

Lrrk2 Pro755leu Variant in Ethnic Chinese Population with Parkinson'S Disease

Penetrance of LRRK2 G2385R and R1628P is Modified by Common PD-associated Genetic Variants

Genetic Analysis of LRRK2 A419V Variant in Ethnic Chinese

Author ' s personal copy Negative results No association of the LRRK 2 genetic variants with Alzheimer ’ s disease in Han Chinese individuals

Association Analysis and Polygenic Risk Score Evaluation of 38 Gwas-Identified Loci in A Chinese Population with Parkinson'S Disease

Glucocerebrosidase L444P Mutation Confers Genetic Risk for Parkinson’s Disease in Central China

Mutational Spectrum and Clinical Features of GBA1 Variants in a Chinese Cohort with Parkinson’s Disease

Lrrk2 Gly2385arg Variant is A Risk Factor of Parkinson'S Disease among Han-Chinese from Mainland China